Back to News
Market Impact: 0.1
One in Three U.S. Adults Delay, Stretch, or Don’t Fill Prescriptions When Costs Are Unclear, According to New Model N Research
Source: GlobeNewswire
Healthcare & BiotechConsumer Demand & Retail
A survey found significant uncertainty around prescription drug prices and limited public awareness of the stakeholders that determine insurance coverage and medication access. The findings highlight ongoing opacity in healthcare pricing and potential barriers for patients, but provide no company-specific financial data or market-moving policy development.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
More News
- Street Calls of The Week
- Coffee giant Dutch Bros made all of its executives, including the CEO, do a two-week bootcamp where they learned how to pour drinks and run stores
- argenx reports positive phase 3 data for autoimmune myositis drug
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup
- Alabama Power spent more than $6 million on ads last year — and customers can be billed for half of them until 2029
- Starter homes cost $1 million in a record 242 U.S. cities—proof the affordability crisis has hit the homes meant for first-time buyers